MarketWatch Automation
Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN -3.01% slipped 5.96% to $9.63 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.04% rising 0.09% to 4,701.70 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.38% rising 0.29% to 36,432.22. Ocugen Inc. closed $9.14 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +0.16% rose 3.18% to $2.27, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +1.89% rose 1.87% to $7.10, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +1.30% fell 1.34% to $121.81. Trading volume (33.9 M) remained 1.7 million below its 50-day average volume of 35.6 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.














